Transformative Non-Invasive/Minimally Invasive Technologies for Imaging the Olfactory System Across Scales (R01 Clinical Trial Optional)
ID: 359696Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Small Businesses

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/359696
Timeline
    Description

    The National Institutes of Health (NIH) is announcing a funding opportunity titled "Transformative Non-Invasive/Minimally Invasive Technologies for Imaging the Olfactory System Across Scales (R01 Clinical Trial Optional)." This initiative aims to solicit research applications focused on developing advanced non-invasive and minimally invasive imaging technologies to visualize the human olfactory system, addressing the current limitations in imaging techniques that hinder understanding of olfactory disorders. The opportunity emphasizes the need for multimodal approaches and encourages collaborations among experts in various fields such as olfaction, biomedical imaging, and bioengineering. Interested applicants should note that applications are not currently being solicited, but they can prepare for submission as the estimated synopsis post date is October 27, 2025, with a closing date of November 27, 2025. For further inquiries, potential applicants can contact Dr. Merav Sabri at merav.sabri@nih.gov or by phone at 301-827-5992.

    Point(s) of Contact
    Merav Sabri, Ph.D. National Institute on Deafness and Other Communication Disorders
    (301) 827-5992
    merav.sabri@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    Mechanisms Underlying Olfactory Dysfunction in Aging and Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Notice of Funding Opportunity (NOFO) aimed at investigating the mechanisms underlying olfactory dysfunction in aging, Alzheimer’s disease (AD), and Alzheimer’s disease-related dementias (ADRD). This initiative seeks to explore the relationship between olfactory decline and various health outcomes in older adults, potentially identifying novel therapeutic targets for disease modification. The research may involve studies on older adults and animal models, utilizing diverse methodologies such as cellular, molecular, and imaging techniques. While applications are not currently being solicited, interested researchers are encouraged to prepare collaborative projects in anticipation of the funding opportunity, which is expected to utilize the R01 activity code. For further inquiries, contact Coryse St. Hillaire-Clarke, Ph.D., at 301-496-9350 or via email at sthillaireclacn@mail.nih.gov. The estimated synopsis post date is August 6, 2026, with a closing date for applications anticipated on October 6, 2026, and awards expected to be made by July 6, 2027.
    In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional)" aimed at advancing imaging technologies for the inner ear. This initiative seeks to support the development of innovative in vivo imaging techniques that can visualize the inner ear's structures with enhanced detail and accuracy, thereby improving the diagnosis and treatment of auditory and vestibular disorders. The program encourages a multidisciplinary approach and supports low-risk clinical trials, with an estimated total funding of $500,000 available for 4-6 awards in FY 2025. Applications are due by May 3, 2025, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Screening for Conditions by Electronic Nose Technology (SCENT III) (Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a cooperative agreement opportunity titled "Screening for Conditions by Electronic Nose Technology (SCENT III)," aimed at developing innovative electronic nose technologies for disease diagnosis and monitoring. This initiative seeks to enhance noninvasive diagnostic platforms that utilize volatile organic compound (VOC) signatures from human skin, thereby improving the detection and analysis of various diseases in everyday settings. The project aligns with the NIH's goal of accelerating the translation of scientific knowledge into effective treatments, with an estimated award date of April 5, 2027, and a project start date on the same day. Interested applicants can reach out to Leah Croucher, PhD, at leah.croucher@nih.gov or by phone at 240-701-2580 for further information.
    Notice of Intent to Publish a Funding Opportunity Announcement for In Vivo Non-Invasive Optical Approaches for Biological systems (UG3/HU3 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is planning to publish a Notice of Funding Opportunity (NOFO) for the "Advancing Non-Invasive Optical Approaches for Biological Systems" initiative, aimed at developing next-generation optical imaging techniques. This initiative seeks to address the challenges of light scattering in biological systems, enabling high-resolution imaging at greater depths within tissues, and will support three-year bi-phasic research projects through UG3/UH3 Cooperative Agreements. With an estimated total program funding of $4.9 million and an award ceiling of $1.6 million, the NIH anticipates issuing the NOFO in December 2024, with applications due by March 2025 and awards expected to be made by December 2025. Interested applicants are encouraged to prepare collaborative proposals in advance of the official announcement.
    Discovery of in vivo Chemical Probes for the Nervous System
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a Notice of Funding Opportunity (NOFO) aimed at supporting the discovery of in vivo chemical probes for the nervous system, specifically targeting novel brain mechanisms. This initiative, led by the National Institute on Aging (NIA) in collaboration with the National Eye Institute (NEI), the National Institute on Drug Abuse (NIDA), and the National Institute of Mental Health (NIMH), seeks applicants who possess validated starting compounds for chemical optimization and bioassays to explore new analog compounds. The focus will be on developing small molecules that can enhance understanding of biological processes relevant to brain diseases, with an emphasis on innovative biological targets. Interested applicants can reach out to Dr. Paul G. Grothaus at grothausp@mail.nih.gov or call 240-688-6634 for further information, with the estimated synopsis posting date set for February 26, 2026, and a projected award date of April 5, 2027.
    Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization (U01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is soliciting applications for a Cooperative Agreement aimed at advancing in vivo high-resolution imaging technologies for inner ear visualization, specifically through the funding opportunity RFA-DC-25-003. This initiative seeks to support high-risk clinical trials that enhance imaging resolution or develop new techniques to visualize inner ear structures in detail, which is crucial for improving diagnostics and treatment of hearing and balance disorders. The program emphasizes the need for advanced imaging technologies to bridge gaps in understanding inner ear pathologies, with a funding ceiling of $500,000 annually over a maximum of five years. Interested applicants can find more information and submit inquiries via grantsinfo@nih.gov, with applications due by October 1, 2026.
    BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System," aimed at advancing neuroscience research through innovative technology development. This initiative seeks applications for the creation of new hardware, software, or molecular constructs that address challenges in recording and modulating neural cells and circuits, with a focus on high-risk projects that could lead to transformative outcomes in understanding dynamic signaling within the central nervous system. The program allocates an estimated $10 million annually for 15-20 awards, emphasizing collaboration across scientific domains and encouraging participation from diverse institutions, particularly those supporting early-career researchers and underserved populations. Interested applicants should note that the application submission deadlines begin on May 2, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01 Basic Experimental Studies with Humans Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a forthcoming funding opportunity titled "BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain" under the U01 cooperative agreement mechanism. This initiative aims to solicit applications for research that investigates fundamental questions in human neuroscience through direct access to the brain, leveraging surgical procedures to explore how the brain senses, perceives, and engages in various cognitive functions. The opportunity encourages collaborative efforts among diverse teams, including clinicians, scientists, and engineers, to propose innovative research plans that could lead to significant insights into nervous system disorders. Interested applicants should prepare for the application process, as the estimated synopsis will be posted on November 28, 2025, with a closing date for applications expected by February 27, 2026. For further inquiries, potential applicants can contact Dr. Hermon R. Gebrehiwet at 240-328-8371 or via email at BRAINResOppHu@ninds.nih.gov.
    Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed)," aimed at encouraging exploratory research to develop advanced microphysiological systems (MPS) that accurately replicate complex human nervous system architectures. This initiative seeks to facilitate studies on nervous system development, function, and aging, particularly in relation to neurological diseases. The R21 grant allows for a budget of up to $275,000 over two years, with applications opening on January 16, 2025, and a submission deadline of January 7, 2026. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Translational Neural Devices (R61/R33 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) titled "Translational Neural Devices (R61/R33 - Clinical Trial Optional)" aimed at advancing the development of therapeutic and diagnostic devices for neurological and neuromuscular disorders. This funding opportunity supports projects through two phases: R61 for non-clinical activities and R33 for small clinical studies, with a focus on ensuring compliance with Environmental Health and Safety regulations. The program emphasizes diversity in applicant teams and requires a Plan for Enhancing Diverse Perspectives, with key deadlines including submission openings starting December 28, 2024, and a close date of January 28, 2027. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.